Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santambrogio, S.
Right arrow Articles by Randazzo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santambrogio, S.
Right arrow Articles by Randazzo, A.

Stroke, Vol 9, 130-132, Copyright © 1978 by American Heart Association


ARTICLES

Is there a real treatment for stroke? Clinical and statistical comparison of different treatments in 300 patients

S Santambrogio, R Martinotti, F Sardella, F Porro and A Randazzo

In the absence of universally accepted criteria for the medical treatment of stroke, we made a rigorously randomized comparative study of different treatments in 300 patients. One group of patients received only a general supportive treatment designed to ensure adequate supplies of water, electrolytes and calories, plus whatever was needed to prevent infection and correct extant associated pathology. Three other groups of patients were treated in the same way but were also given, respectively, one of the following medications: Hydergine (Sandoz) (a mixture of three ergot alkaloids), dexamethasone, and mannitol. No statistically significant difference emerged among any of the treatment groups and the reference group in terms of objective therapeutic results. The authors concluded that, at least with the dosage used in this study, none of the treatments proved more useful than conventional supportive therapy in the first 10 days after a stroke.


This article has been cited by other articles:


Home page
StrokeHome page
J. Bardutzky and S. Schwab
Antiedema Therapy in Ischemic Stroke
Stroke, November 1, 2007; 38(11): 3084 - 3094.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Bereczki, L. Mihalka, S. Szatmari, K. Fekete, D. Di Cesar, B. Fulesdi, L. Csiba, and I. Fekete
Mannitol Use in Acute Stroke: Case Fatality at 30 Days and 1 Year
Stroke, July 1, 2003; 34(7): 1730 - 1735.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Bereczki, M. Liu, G. F. d. Prado, and I. Fekete
Cochrane Report : A Systematic Review of Mannitol Therapy for Acute Ischemic Stroke and Cerebral Parenchymal Hemorrhage
Stroke, November 1, 2000; 31(11): 2719 - 2722.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P DESAI and K PRASAD
Dexamethasone is not necessarily unsafe in primary supratentorial intracerebral haemorrhage
J. Neurol. Neurosurg. Psychiatry, November 1, 1998; 65(5): 799a - 801.
[Full Text]


Home page
ANGIOLOGYHome page
G.G. Nenci, P. Gresele, M. Taramelli, G. Agnelli, and E. Signorini
Thrombolytic Therapy for Thromboembolism of Vertebrobasilar Artery
Angiology, September 1, 1983; 34(9): 561 - 571.
[Abstract] [PDF]